The FMHR traders discuss their strategies for the fiscal cliff. Meanwhile Chad Morganlander, Washington Crossing Advisors, says investors should be more conservative with their portfolios. And Gilead soars on some positive new data on its next-gen hepatitis C treatment, reports CNBC's Courtney Reagan.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT